tiprankstipranks
Trending News
More News >
Nuo Therapeutics Inc (AURX)
:AURX
US Market
Advertisement

Nuo Therapeutics (AURX) Ratios

Compare
12 Followers

Nuo Therapeutics Ratios

AURX's free cash flow for Q1 2025 was $0.75. For the 2025 fiscal year, AURX's free cash flow was decreased by $ and operating cash flow was $-1.54. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
0.47 2.32 4.39 0.22 0.23
Quick Ratio
0.39 2.01 3.99 0.22 0.23
Cash Ratio
0.04 1.38 3.42 0.22 0.23
Solvency Ratio
-1.70 -3.66 -3.45 0.00 -0.07
Operating Cash Flow Ratio
-1.30 -4.70 -6.17 -0.02 -0.01
Short-Term Operating Cash Flow Coverage
-24.11 0.00 -46.65 0.00 0.00
Net Current Asset Value
$ -758.32K$ 724.71K$ 1.78M$ -522.54K$ -515.79K
Leverage Ratios
Debt-to-Assets Ratio
0.13 0.14 0.11 0.00 0.00
Debt-to-Equity Ratio
-0.70 0.25 0.15 0.00 0.00
Debt-to-Capital Ratio
-2.28 0.20 0.13 0.00 0.00
Long-Term Debt-to-Capital Ratio
-0.59 0.00 0.00 0.00 0.00
Financial Leverage Ratio
-5.38 1.81 1.39 -0.29 -0.30
Debt Service Coverage Ratio
-36.19 -968.70 -36.16 0.00 -6.96
Interest Coverage Ratio
1.56K -1.00K -1.58K- -7.81
Debt to Market Cap
<0.01 0.00 <0.01 0.00 0.00
Interest Debt Per Share
<0.01 <0.01 <0.01 0.00 <0.01
Net Debt to EBITDA
-0.04 0.22 0.55 0.00 0.53
Profitability Margins
Gross Profit Margin
76.89%79.28%82.88%0.00%0.00%
EBIT Margin
-146.36%-520.65%-2823.73%0.00%0.00%
EBITDA Margin
-151.42%-503.35%-2757.73%0.00%0.00%
Operating Profit Margin
-154.41%-520.65%-2958.21%0.00%0.00%
Pretax Profit Margin
-146.20%-521.17%-2825.60%0.00%0.00%
Net Profit Margin
-146.20%-521.17%-2695.14%0.00%0.00%
Continuous Operations Profit Margin
-146.20%-521.17%-2825.60%0.00%0.00%
Net Income Per EBT
100.00%100.00%95.38%100.00%153.25%
EBT Per EBIT
94.68%100.10%95.52%100.00%24.04%
Return on Assets (ROA)
-205.89%-168.88%-99.28%-60.47%-90.97%
Return on Equity (ROE)
-527.75%-305.20%-138.06%17.35%27.00%
Return on Capital Employed (ROCE)
1859.28%-263.29%-135.70%17.35%73.30%
Return on Invested Capital (ROIC)
3838.64%-244.70%-121.55%54960509.97%112.33%
Return on Tangible Assets
-205.89%-168.88%-99.28%-60.47%-90.97%
Earnings Yield
-3.60%-13.70%-5.04%-2992.77%-1.20%
Efficiency Ratios
Receivables Turnover
5.84 2.43 1.22 0.00 0.00
Payables Turnover
0.56 0.32 0.05 0.00 0.00
Inventory Turnover
3.76 0.60 0.08 0.00 0.00
Fixed Asset Turnover
2.96 1.94 0.27 0.00 0.00
Asset Turnover
1.41 0.32 0.04 0.00 0.00
Working Capital Turnover Ratio
-7.76 0.42 0.15 0.00 0.00
Cash Conversion Cycle
-487.95 -384.94 -2.70K 0.00 0.00
Days of Sales Outstanding
62.50 150.37 300.19 0.00 0.00
Days of Inventory Outstanding
96.98 606.70 4.56K 0.00 0.00
Days of Payables Outstanding
647.42 1.14K 7.55K 0.00 0.00
Operating Cycle
159.47 757.07 4.86K 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
-0.04 -0.08 -0.09 >-0.01 >-0.01
Free Cash Flow Per Share
-0.04 -0.08 -0.09 >-0.01 >-0.01
CapEx Per Share
<0.01 <0.01 <0.01 0.00 0.00
Free Cash Flow to Operating Cash Flow
1.23 1.00 1.02 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
-4.33 -437.30 -61.78 0.00 0.00
Capital Expenditure Coverage Ratio
-4.33 -437.30 -61.78 0.00 0.00
Operating Cash Flow Coverage Ratio
-11.26 -12.39 -11.06 0.00 0.00
Operating Cash Flow to Sales Ratio
-1.03 -5.21 -33.02 0.00 0.00
Free Cash Flow Yield
-3.13%-13.72%-6.28%-429.16%-0.09%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-27.76 -7.30 -19.83 -0.03 -83.02
Price-to-Sales (P/S) Ratio
40.59 38.03 534.54 0.00 0.00
Price-to-Book (P/B) Ratio
-307.61 22.27 27.38 >-0.01 -22.42
Price-to-Free Cash Flow (P/FCF) Ratio
-31.94 -7.29 -15.93 -0.23 -1.17K
Price-to-Operating Cash Flow Ratio
-39.31 -7.31 -16.19 -0.23 -1.17K
Price-to-Earnings Growth (PEG) Ratio
3.59 27.58 >-0.01 <0.01 0.91
Price-to-Fair Value
-307.61 22.27 27.38 >-0.01 -22.42
Enterprise Value Multiple
-26.84 -7.34 -18.83 0.00 -39.59
Enterprise Value
65.64M 22.47M 58.29M -145.40K 11.41M
EV to EBITDA
-26.84 -7.34 -18.83 0.00 -39.59
EV to Sales
40.65 36.92 519.25 0.00 0.00
EV to Free Cash Flow
-31.99 -7.08 -15.48 11.18 -1.16K
EV to Operating Cash Flow
-39.37 -7.09 -15.73 11.18 -1.16K
Tangible Book Value Per Share
>-0.01 0.02 0.05 -0.02 -0.02
Shareholders’ Equity Per Share
>-0.01 0.02 0.05 -0.02 -0.02
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.05 -3.17M -0.53
Revenue Per Share
0.03 0.01 <0.01 0.00 0.00
Net Income Per Share
-0.05 -0.08 -0.08 >-0.01 >-0.01
Tax Burden
1.00 1.00 0.95 1.00 1.53
Interest Burden
1.00 1.00 1.00 1.00 0.24
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.05 0.04 0.08 0.00 0.00
Income Quality
0.71 1.00 1.17 0.68 0.80
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis